Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Differential Expression of Immune Repertoire of T/B Lymphocytes in Ovarian High Grade Serous Carcinoma

NCT03794115 is registered in ClinicalTrials.gov with Lei Li as lead sponsor.

NCT NCT03794115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03794115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Differential Expression of Immune Repertoire of T/B Lymphocytes in Ovarian High Grade Serous Carcinoma
Lead sponsor
Lei Li
Phase
Observational
Overall status
Unknown status
Start date
January 3, 2019
Completion date
January 1, 2022
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

b lymphocyte receptor, immune repertoire, ovarian high grade serous carcinoma, t lymphocyte receptor